Skip to Content

A5 (Iclusig 15 mg)

Generic Name: ponatinib

Pill with imprint A5 is White, Round and has been identified as Iclusig 15 mg. It is supplied by ARIAD Pharmaceuticals, Inc..

Iclusig is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia and belongs to the drug classes BCR-ABL tyrosine kinase inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A5

Iclusig 15 mg A5

Iclusig

Generic Name
ponatinib
Imprint
A5
Strength
15 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors, Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
ARIAD Pharmaceuticals, Inc.
National Drug Code (NDC)
76189-0535
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, sodium starch glycolate type B potato, silicon dioxide, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "A5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.